Y010-0660 Screening compound: ethyl 2-(methylsulfanyl)-4-[(3-phenyl-1,2-oxazol-5-yl)amino]pyrimidine-5-carboxylate

Y010-0660 Screening compound: ethyl 2-(methylsulfanyl)-4-[(3-phenyl-1,2-oxazol-5-yl)amino]pyrimidine-5-carboxylate
Y010-0660 Screening compound: ethyl 2-(methylsulfanyl)-4-[(3-phenyl-1,2-oxazol-5-yl)amino]pyrimidine-5-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound Y010-0660
ethyl 2-(methylsulfanyl)-4-[(3-phenyl-1,2-oxazol-5-yl)amino]pyrimidine-5-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y010-0660

Molecular Formula

C17H16N4O3S (C17 H16 N4 O3 S)

Compound Name

ethyl 2-(methylsulfanyl)-4-[(3-phenyl-1,2-oxazol-5-yl)amino]pyrimidine-5-carboxylate

IUPAC name

ethyl 2-(methylsulfanyl)-4-[(3-phenyl-12-oxazol-5-yl)amino]pyrimidine-5-carboxylate

SMILES

CCOC(c(cn1)c(Nc2cc(-c3ccccc3)no2)nc1SC)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

356.41

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.332

Distribution Coefficient, logD

4.332

Water Solubility, LogSw

-4.13

Polar Surface Area

70.640

Acid Dissociation Constant (pKa)

12.19

Base Dissociation Constant (pKb)

1.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.60

Y010-0660 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with Y010-0660 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y010-0660?
Check Price and Availability of Y010-0660, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y010-0660 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y010-0660
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y010-0660
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y010-0660 available by request